* This is the Professional Version. *
Bronchoscopy is introduction of an endoscope into the airways. Flexible fiberoptic bronchoscopy has replaced rigid bronchoscopy for virtually all diagnostic, and most therapeutic, indications.
Rigid bronchoscopy is now used only when a wider aperture and channels are required for better visualization and instrumentation such as when
Investigating vigorous pulmonary hemorrhage (in which the rigid bronchoscope can better identify the bleeding source and, with its larger suction channel, can better suction the blood and prevent asphyxiation)
Viewing and removing aspirated foreign bodies in young children
Viewing obstructive endobronchial lesions (requiring laser debulking or stent placement)
Flexible bronchoscopes are nearly all color video–compatible, facilitating airway visualization and documentation of findings.
Diagnostically, flexible fiberoptic bronchoscopy allows for
Therapeutic uses include suctioning of retained secretions, endobronchial stent placement, and balloon dilation of airway stenoses.
Indications for Flexible Fiberoptic Bronchoscopy
Absolute contraindications include
Relative contraindications include
Transbronchial biopsy should be done with caution in patients with uremia, superior vena cava obstruction, or pulmonary hypertension because of increased risk of bleeding. Inspection of the airways is safe in these patients, however.
Bronchoscopy should be done only by a pulmonologist or trained surgeon in a monitored setting, typically a bronchoscopy suite, operating room, or ICU (for ventilated patients).
Patients should receive nothing by mouth for at least 6 h before bronchoscopy and have IV access, intermittent BP monitoring, continuous pulse oximetry, and cardiac monitoring. Supplemental O2 should be used. Premedication with atropine 0.01 mg/kg IM or IV to decrease secretions and vagal tone is common, although this practice has been called into question by recent studies. Patients usually receive conscious sedation with short-acting benzodiazepines, opioids, or both before the procedure to decrease anxiety, discomfort, and cough. In some centers, general anesthesia (eg, deep sedation with propofol and airway control via endotracheal intubation or use of a laryngeal mask airway) is commonly used before bronchoscopy.
The pharynx and vocal cords are anesthetized with nebulized or aerosolized lidocaine (1 or 2%, to a maximum of 250 to 300 mg for a 70-kg patient). The bronchoscope is lubricated and passed through the nostril, the mouth with use of an oral airway or bite block, or an artificial airway such as an endotracheal tube. After inspecting the nasopharynx and larynx, the clinician passes the bronchoscope through the vocal cords during inspiration, into the trachea and then further distally into the bronchi.
Several ancillary procedures can be done as needed, with or without fluoroscopic guidance:
Bronchial washing: Saline is injected through the bronchoscope and subsequently aspirated from the airways.
Bronchial brushing: A brush is advanced through the bronchoscope and used to abrade suspicious lesions to obtain cells.
Bronchoalveolar lavage: 50 to 200 mL of sterile saline is infused into the distal bronchoalveolar tree and subsequently suctioned out, retrieving cells, protein, and microorganisms located at the alveolar level. Local areas of pulmonary edema created by lavage may cause transient hypoxemia.
Transbronchial biopsy: Forceps are advanced through the bronchoscope and airway to obtain samples from one or more sites in the lung parenchyma. Transbronchial biopsy can be done without x-ray guidance, but evidence supports increased diagnostic yields and lower incidence of pneumothorax when fluoroscopic guidance is used.
Transbronchial needle aspiration: A retractable needle is inserted through the bronchoscope and can be used to sample enlarged mediastinal lymph nodes or masses.
Patients are typically given supplemental O2 and observed for 2 to 4 h after the procedure. Return of a gag reflex and maintenance of O2 saturation when not receiving O2 are the two primary indices of recovery. Standard practice is to obtain a posteroanterior chest x-ray after transbronchial lung biopsy to exclude pneumothorax.
Serious complications are uncommon; minor bleeding from a biopsy site and fever occur in 10 to 15% of patients. Premedication can cause oversedation with respiratory depression, hypotension, and cardiac arrhythmias. Rarely, topical anesthesia causes laryngospasm, bronchospasm, seizures, methemoglobinemia with refractory cyanosis, or cardiac arrhythmias or arrest.
Bronchoscopy itself may cause minor laryngeal edema or injury with hoarseness, hypoxemia in patients with compromised gas exchange, arrhythmias (most commonly premature atrial contractions, ventricular premature beats, or bradycardia), and, very rarely, transmission of infection from suboptimally sterilized equipment. Mortality is 1 to 4/10,000 patients. The elderly and patients with serious comorbidities (severe COPD, coronary artery disease, pneumonia with hypoxemia, advanced cancers, mental dysfunction) are at greatest risk.
Transbronchial biopsy can cause pneumothorax (2 to 5%), significant hemorrhage (1 to 1.5%), or death (0.1%), but doing the procedure can often avoid the need for thoracotomy.
Drug NameSelect Brand Names
Was This Page Helpful?
* This is the Professional Version. *